BlackRock Portfolio holdings
BlackRock, Inc., founded in 1988 by Larry Fink and a group of partners, is the world’s largest asset management firm, headquartered in New York City. Initially starting as a risk management and fixed-income institutional asset manager, it has grown to manage over $10 trillion in assets through a combination of organic growth and strategic acquisitions, such as its 2009 purchase of Barclays Global Investors. BlackRock is known for its extensive range of investment products, including mutual funds, ETFs (notably under the iShares brand), and alternative investments, serving clients ranging from individuals to governments.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Warner Bros
WBD
|
+$2.81B |
| 2 |
Linde
LIN
|
+$2.35B |
| 3 |
Chevron
CVX
|
+$1.53B |
| 4 |
Pfizer
PFE
|
+$1.38B |
| 5 |
UnitedHealth
UNH
|
+$1.35B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AT&T
T
|
+$3.75B |
| 2 |
CERN
Cerner Corp
CERN
|
+$2.23B |
| 3 |
AZPN
ASPEN TECHNOLOGY INC
AZPN
|
+$1.1B |
| 4 |
Baidu
BIDU
|
+$1.07B |
| 5 |
NXP Semiconductors
NXPI
|
+$998M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.26% |
| 2 | Healthcare | 15.23% |
| 3 | Financials | 12.33% |
| 4 | Consumer Discretionary | 9.59% |
| 5 | Industrials | 8.36% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4676
NanoViricides
NNVC
$38.8M
| $302K | ﹤0.01% |
160,948
-28,548
| -15% | -$52.5K |
|
4677
Summit Therapeutics
SMMT
$10.4B
| $302K | ﹤0.01% |
302,208
-1,062,985
| -78% | -$1.49M |
|
|
ADIL
4678
Adial Pharmaceuticals
ADIL
$7.31M
| $301K | ﹤0.01% |
360
-1
| -0.3% | -$906 |
|
|
ALPP
4679
DELISTED
Alpine 4 Holdings Inc
ALPP
| $301K | ﹤0.01% |
52,949
-5,593
| -10% | -$35.9K |
|
|
PW
4680
Power REIT
PW
$3.01M
| $299K | ﹤0.01% |
2,346
+105
| +5% | +$25.4K |
|
4681
Applied Digital
APLD
$7.89B
| $298K | ﹤0.01% |
+284,411
| New | +$852K |
|
4682
Surrozen
SRZN
$258M
| $298K | ﹤0.01% |
6,609
+4,196
| +174% | +$171K |
|
|
STEX
4683
Streamex Corp
STEX
$74M
| $296K | ﹤0.01% |
44,986
-7,379
| -14% | -$69.3K |
|
4684
Cohen & Co
COHN
$33.3M
| $296K | ﹤0.01% |
27,465
-1,685
| -6% | -$24.7K |
|
|
ORGS
4685
DELISTED
Orgenesis Inc. Common Stock
ORGS
| $295K | ﹤0.01% |
12,208
-564
| -4% | -$15.7K |
|
4686
iShares Low Carbon Optimized MSCI ACWI ETF
CRBN
$1.15B
| $293K | ﹤0.01% |
2,141
+103
| +5% | +$15.3K |
|
4687
First National Corp
FXNC
$287M
| $293K | ﹤0.01% |
16,084
+1,425
| +10% | +$28.5K |
|
4688
Cumberland Pharmaceuticals
CPIX
$100M
| $292K | ﹤0.01% |
140,248
+1,346
| +1% | +$3.11K |
|
|
MRIN
4689
DELISTED
Marin Software
MRIN
| $292K | ﹤0.01% |
29,452
+5,811
| +25% | +$74.3K |
|
4690
Soluna Holdings
SLNH
$192M
| $292K | ﹤0.01% |
2,875
-14
| -0.5% | -$2.73K |
|
|
NDAC
4691
DELISTED
NightDragon Acquisition Corp. Class A Common stock
NDAC
| $292K | ﹤0.01% |
+29,949
| New | +$293K |
|
|
RNDB
4692
DELISTED
Randolph Bancorp, Inc. Common Stock
RNDB
| $292K | ﹤0.01% |
11,058
-451
| -4% | -$11.8K |
|
4693
Abeona Therapeutics
ABEO
$366M
| $291K | ﹤0.01% |
55,764
-12,021
| -18% | -$60.8K |
|
4694
NCS Multistage Holdings
NCSM
$123M
| $291K | ﹤0.01% |
9,404
+994
| +12% | +$41.5K |
|
4695
cbdMD
YCBD
$5.32M
| $288K | ﹤0.01% |
1,815
-233
| -11% | -$55.2K |
|
4696
CB Financial Services
CBFV
$186M
| $287K | ﹤0.01% |
12,567
-1,147
| -8% | -$25.7K |
|
4697
Fennec Pharmaceuticals
FENC
$332M
| $287K | ﹤0.01% |
51,369
-3,970
| -7% | -$23K |
|
|
MOR
4698
DELISTED
MorphoSys AG American Depositary Shares
MOR
| $282K | ﹤0.01% |
58,356
-77,830
| -57% | -$430K |
|
|
RVLP
4699
DELISTED
RVL Pharmaceuticals plc Ordinary Shares
RVLP
| $282K | ﹤0.01% |
207,178
-5,009
| -2% | -$7.25K |
|
4700
Bowman Consulting
BWMN
$470M
| $281K | ﹤0.01% |
22,764
-1,243
| -5% | -$19.1K |
|
Similar funds
BlackRock's Q2 2022 Portfolio in Review
As of Q2 2022, BlackRock held 6,138 positions worth $3.12T, down 16% from $3.71T the previous quarter. Its ten largest holdings account for 19% of the portfolio.
BlackRock's Q2 2022 filing shows 278 new, 2,738 increased, 2,355 reduced and 221 closed positions. Its largest new stake was Aspen Technology Inc: 2,824,931 shares worth $519M. The largest sale was AT&T, an estimated $3.75B.
By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 24% a quarter earlier, followed by Healthcare and Financials.
- BlackRock's largest Q2 2022 buy was Aspen Technology Inc: 2,824,931 shares worth $519M.
- BlackRock added most to Warner Bros in Q2 2022, an estimated $2.81B increase.
- BlackRock's biggest Q2 2022 reduction was AT&T, cutting an estimated $3.75B.
- BlackRock fully exited Cerner Corp in Q2 2022, selling an estimated $2.23B.
- BlackRock's ten largest holdings make up 19% of its $3.12T portfolio in Q2 2022.
- BlackRock opened 278 new positions and closed 221 in Q2 2022.
- BlackRock's portfolio value fell 16% quarter-over-quarter to $3.12T.
Based on BlackRock's 13F filing for Q2 2022, filed 12 Aug 2022.